Catalyst Wire Dossier Catalyst Wire Dossier

Second-generation AI-based therapeutic regimen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Second-generation AI-based therapeutic regimen, covering 2023-09-22 to 2023-09-22. Get the full timeline:

Most recent: Clinical Trial Update: A Second-generation AI Based Therapeutic Regimen in Patients With Gaucher Disease Treated With Enzyme Replacement Therapy. [Phase 2]

See pricing